Evaluation of the Efficacy of the Individually Adjusted Therapy Scale (ATI) on the Addiction Severity
NCT ID: NCT03606759
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
151 participants
INTERVENTIONAL
2019-07-31
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Research on the Efficacy of the "T.O.P. Computer Training" Procedure in the Treatment of Alcohol Dependence
NCT03338361
Brief Interventions for Drop-out Re-engagement
NCT00350571
Machine Learning Technology in Predicting Relapse and Implementing Peer Recovery Intervention Before Drug Use Occurs
NCT05976672
Peer-led Personalized Support Program
NCT05918601
Learning and Relapse Risk in Alcohol Dependence (FP2)
NCT02615977
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All the participants will be assessed with several questionnaires that evaluate the history and the severity of addiction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traitment as usual adjusted on ATI information
Assessments with a multidisciplinary team (doctors, nurses, psychologists, psychiatrists, social workers) once a week during 3 months.
Weekly assessment ajusted
Weekly assessment during 3 months :
Severity of addiction (Addiction Severity Index, ASI) Mini International Neuropsychiatric Interview, MINI Craving intensity (BILAN-7 jours) Individual cues of each participant (QSA) Substance use and gambling (BILAN-7 jours) Individually Adjusted Therapy scale (ATI)
Traitment as usual
Assessments with a multidisciplinary team (doctors, nurses, psychologists, psychiatrists, social workers) once a week during 3 months.
Weekly assessment
Weekly assessment during 3 months :
Severity of addiction (Addiction Severity Index, ASI) Mini International Neuropsychiatric Interview, MINI Craving intensity (BILAN-7 jours) Individual cues of each participant (QSA) Substance use and gambling (BILAN-7 jours)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weekly assessment
Weekly assessment during 3 months :
Severity of addiction (Addiction Severity Index, ASI) Mini International Neuropsychiatric Interview, MINI Craving intensity (BILAN-7 jours) Individual cues of each participant (QSA) Substance use and gambling (BILAN-7 jours)
Weekly assessment ajusted
Weekly assessment during 3 months :
Severity of addiction (Addiction Severity Index, ASI) Mini International Neuropsychiatric Interview, MINI Craving intensity (BILAN-7 jours) Individual cues of each participant (QSA) Substance use and gambling (BILAN-7 jours) Individually Adjusted Therapy scale (ATI)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meet DSM-5 substance use disorder diagnosis for at least one substance (alcohol, tobacco, cannabis, opiates, cocaine or any other substance) use disorder or behavioral addiction (gambling, screens, video games, food addiction, sex addiction, compulsive purchases), currently not stabilized
* Seek treatment for this a substance use disorder or behavioral addiction
* Beginning (or re-initiating) multi-month outpatient care for this disorder in one of the inclusion centres.
* Ability to identify a priority substance/behavior, as main object of treatment, in case of simultaneous treatment on several addictions
* Beneficiary of the French Social Security system
* Give an informed consent to participate
Exclusion Criteria
* Severe physical or psychiatric condition that prevents to complete the assessment
* Addictive disorder that requires several treatment for several substance use disorder simultaneously
* Difficulty to understand and to write French
* Could not be reachable by phone
* Participate to another study that prevents to participate to another research
* Prisoner
* Person under law protection
* Person under legal guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mélina Fatseas
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bordeaux University Hospital
Bordeaux, , France
Centre Hospitalier Charles Perrens
Bordeaux, , France
Centre Hospitalier Esquirol
Limoges, , France
Centre Hospitalier Universitaire La Réunion
Saint-Denis, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2014/43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.